European Society of Toxicology In Vitro > Corporate news > ESTIV Corporate member’s event: EPISKIN ACADEMY Webinar
30 April 2021

ESTIV Corporate member’s event: EPISKIN ACADEMY Webinar

SECOND EPISKIN ACADEMY WEBINAR, TUESDAY, JUNE 01, 2021, 9 AM CET & 4 PM CET

ADDRESSING IN VITRO EYE IRRITATION WITH THE SKINETHIC HCE : RECENT DEVELOPMENTS AND LIVE LAB SESSION

Validated and integrated in the OECD TG492 guideline, the SkinEthic HCE model allows to replace the animal to identify products not requiring classification for eye irritation. This webinar will present the characterization of this model, its specificities and the importance of quality control in its manufacturing process to deliver a model with high performance every week.

Its use in the framework of the OECD guidance Document on Integrated Approaches to Testing and Assessment (IATA) for Serious Eye Damage and Eye Irritation for regulatory toxicology will be presented as well as the new perspectives opened by the ongoing validation of the Time to toxicity method to identify mild irritants (category 3).

The last part of the webinar will be dedicated to a laboratory tutorial on the use of the SkinEthic HCE model.

REGISTRATION LINK: https://episkin.com/Training/Episkin-Training-WebSession-Form

During the Q&A session, our experts will answer your questions on this complex topic of replacement of the animal for eye irritation. (Complete agenda will soon be available online) For the first time this digital event will be live 2 times a day in order to adapt to your countries best time to attend to it. After registration you will receive an automatic e-mail sending you both sessions’ links, book the one you prefer in your agenda!

Related content

The new Biomedical research report from ECVAM: Tackling neurodegenerative diseases with more human relevant research

To promote more human relevant research, the JRC’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) led a study to review advanced non-animal models used in the field of neurodegenerative diseases, specifically for Parkinson’s and Alzheimer’s.

Microphysiological Systems (MPS) World Summit: Towards Regulatory Acceptance

  • News

The MPS (Microphysiological Systems) World Summit will bring together a global audience, including institutions (government, health foundations, charities), the academic research community (universities, research institutes), environmental and human toxicity researchers, the pharmaceutical and other industries…

Corporate Members

mattek in Vitro Life Science Laboratories

Affiliated Societies

Invitrom Celltox IVTS

Memorandum of Understanding